Trials / Completed
CompletedNCT00210678
A Study to Evaluate Intravaginal Ejaculation Time in Men With and Without Premature Ejaculation
An Observational Study to Evaluate Intravaginal Ejaculatory Latency Time and Patient-Reported Outcomes in Men With and Without Premature Ejaculation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,115 (actual)
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to characterize intravaginal ejaculatory latency time (time between the start of vaginal intercourse and the start of intravaginal ejaculation) in men with and without premature ejaculation (PE) and to assess the validity of patient-reported outcomes.
Detailed description
This is a multinational, multicenter, observational study in men with and without PE. The study consists of three visits: one visit for screening and enrollment, and two visits for observation after 1 and 2 months (total duration of 8 weeks). No study treatment for PE is administered to patients during the course of the study. Patients and their partners are expected to attempt sexual intercourse at least 2 times a week during the 8-week study period and to use a stopwatch to record the intravaginal ejaculatory latency time (IELT) during intercourse. At visits during the observation period "patients" (and/or partners if partners are responsible for completing questionaires) also provide patient-reported outcomes (PROs) by answering several questionnaires that include the topics of control over ejaculation, satisfaction with sexual intercourse, personal distress, interpersonal difficulty, and self-esteem. The study will estimate the distribution of the average IELT values for men with PE and men without PE.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | No intervention | No treatment is given to the patients as this is an observational study. |
Timeline
- Start date
- 2005-03-01
- Primary completion
- 2005-09-01
- Completion
- 2005-09-01
- First posted
- 2005-09-21
- Last updated
- 2012-10-10
Source: ClinicalTrials.gov record NCT00210678. Inclusion in this directory is not an endorsement.